Smallpox: Vaccine reactions and contraindications

Dermatologic Clinics

Volumn 22, Issue 3, 2004, Pages 275-289

  Tom, Wynnis L ^a   Kenner, Julie R ^b   Friedlander, Sheila F ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Castle Medical Center   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPRURITIC AGENT; ANTIVIRUS AGENT; BCG VACCINE; CHICKENPOX VACCINE; CIDOFOVIR; CORTICOSTEROID; DIPHTHERIA VACCINE; EYE DROPS; FLUOROURACIL; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISOTRETINOIN; MEASLES VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOTIDE DERIVATIVE; ORAL POLIOMYELITIS VACCINE; PERTUSSIS VACCINE; PREDNISONE; SMALLPOX VACCINE; STEROID; TETANUS TOXOID; TRIFLURIDINE; UNINDEXED DRUG; VACCINIA VACCINE; VIDARABINE; VIRUS VACCINE; YELLOW FEVER VACCINE;

AMNESIA; ANGINA PECTORIS; APHASIA; ATOPIC DERMATITIS; BIOLOGICAL WARFARE; BRAIN DISEASE; BRAIN EDEMA; CENTRAL NERVOUS SYSTEM DISEASE; CHILL; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONJUNCTIVITIS; CYTOMEGALOVIRUS INFECTION; DEATH; ECZEMA; EDEMA; ENCEPHALITIS; ENCEPHALOMYELITIS; EROSION; ERYTHEMA; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM LEPROSUM; EYE DISEASE; FATIGUE; FEVER; GUILLAIN BARRE SYNDROME; HEADACHE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMIPLEGIA; HUMAN; HYPERSENSITIVITY REACTION; IRITIS; ISCHEMIC HEART DISEASE; KERATITIS; KERATOPATHY; LYMPHADENOPATHY; LYMPHANGITIS; MALAISE; MYALGIA; MYELITIS; MYOCARDITIS; NAUSEA; NEURITIS; NEUROLOGICAL COMPLICATION; NONHUMAN; OSTEOMYELITIS; PAIN; PAPULE; PARALYSIS; PERICARDITIS; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; PRURITUS; PUSTULE; RASH; REVIEW; SEIZURE; SKIN INDURATION; SMALLPOX; STEVENS JOHNSON SYNDROME; TERRORISM; URTICARIA; VACCINATION REACTION; VACCINIA; XEROSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; MALE; PRIMARY PREVENTION; PROGNOSIS; RISK ASSESSMENT; SMALLPOX; SMALLPOX VACCINE; SURVIVAL RATE; UNITED STATES; VACCINATION;

EID: 2942639494     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.03.006     Document Type: Review

References (64)

1. World Health Organization. Global Commission for the Certification of Smallpox Eradication The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication, Geneva, December 1979. 1980;World Health Organization, Albany (NY)
2. Brock T.D. Microorganisms: from smallpox to lyme disease: readings from Scientific American magazine. 1990;Freeman, New York
3. Fenner F. Smallpox and its eradication. 1988;World Health Organization, Geneva
4. Roddis L.H. Edward Jenner and the discovery of smallpox vaccination. 1930;George Banta Publishing Company, Menasha
5. Bazin H., Jenner E. The eradication of smallpox: Edward Jenner and the first and only eradication of a human infectious disease. 2000;Academic Press, San Diego (CA)
6. Bray M. Pathogenesis and potential antiviral therapy of complications of smallpox vaccination. Antiviral Res. 58:2003;101-114
7. Smallpox vaccine. Med Lett Drugs Ther. 45:2003;1-4
8. Bicknell W.J. The case for voluntary smallpox vaccination. N Engl J Med. 346:2002;1323-1325
9. Cohen J. Bioterrorism. Smallpox vaccinations: how much protection remains? Science. 294:2001;985
10. Bartlett J., Borio L., Radonovich L., Mair J.S., O'Toole T., Mair M., et al. Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis. 36:2003;883-902
11. Couzin J. Smallpox immunization. Panel urges caution over heart problems. Science. 300:2003;2013-2015
12. CDC Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep. 50:2001;1-25
13. Arita I. Duration of immunity after smallpox vaccination: a study on vaccination policy against smallpox bioterrorism in Japan. Jpn J Infect Dis. 55:2002;112-116
14. Wharton M., Strikas R.A., Harpaz R., Rotz L.D., Schwartz B., Casey C.G., et al. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 52:2003;1-16
15. Plotkin S.A., Orenstein W.A. Vaccines. 3rd edition:1999;W.B. Saunders Co. Philadelphia
16. Smithwick E.M., Steiner M., Quick J.D. Vaccinia virus and tuberculin reactivity. Pediatrics. 50:1972;660-661
17. Goldstein J.A., Neff J.M., Lane J.M., Koplan J.P. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 55:1975;342-347
18. World Health Organization Expert Committee on Smallpox. First report. 1964;WHO, Geneva
19. Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 346:2002;1265-1274
20. Cono J., Casey C.G., Bell D.M. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep. 52:2003;1-28
21. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis. 122:1970;303-309
22. Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968. N Engl J Med. 281:1969;1201-1208
23. Habif T.P. Clinical dermatology: a color guide to diagnosis and therapy. 3rd edition:1996;Mosby, St. Louis
24. Neff J.M., Levine R.H., Lane J.M., Ager E.A., Moore H., Rosenstein B.J., et al. Complications of smallpox vaccination United States 1963. II. Results obtained by four statewide surveys. Pediatrics. 39:1967;916-923
25. Humphrey D. Localized accidental vaccinia of the vulva: report of 3 cases and a review of the world literature. Am J Obstet Gynecol. 86:1963;460
26. Ruben F.L., Lane J.M. Ocular vaccinia. An epidemiologic analysis of 348 cases. Arch Ophthalmol. 84:1970;45-48
27. Semba R.D. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol. 121:2003;715-719
28. Vastag B. Experts weigh prevention, therapy for ocular vaccinia in smallpox vaccinees. JAMA. 289:2003;2198-2199
29. Carney J.F., Caroline N.L., Nankervis G.A., Pomeranz J.R. Eczema vaccinatum and eczema herpeticum in Darier disease. Arch Dermatol. 107:1973;613-614
30. Neff J.M., Lane J.M., Fulginiti V.A., Henderson D.A. Contact vaccinia - transmission of vaccinia from smallpox vaccination. JAMA. 288:2002;1901-1905
31. Kempe C.H. Studies on smallpox and complications of smallpox vaccination. Pediatrics. 26:1960;176-189
32. Breman J.G., Henderson D.A. Diagnosis and management of smallpox. N Engl J Med. 346:2002;1300-1308
33. Bray M., Wright M.E. Progressive vaccinia. Clin Infect Dis. 36:2003;766-774
34. Cleri D.J., Villota F.J., Porwancher R.B. Smallpox, bioterrorism, and the neurologist. Arch Neurol. 60:2003;489-494
35. DeVries E. Postvaccinial perivenous encephalitis. 1959;Elsevier, Amsterdam
36. Levine M.M. Live-virus vaccines in pregnancy. Risks and recommendations. Lancet. 2:1974;34-38
37. Suarez V.R., Hankins G.D. Smallpox and pregnancy: from eradicated disease to bioterrorist threat. Obstet Gynecol. 100:2002;87-93
38. Sepkowitz K.A. How contagious is vaccinia? N Engl J Med. 348:2003;439-446
39. CDC Update. Cardiac-related events during the civilian smallpox vaccination program - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;492-496
40. Halsell J.S., Riddle J.R., Atwood J.E., Gardner P., Shope R., Poland G.A., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 289:2003;3283-3289
41. Feery B.J. Adverse reactions after smallpox vaccination. Med J Aust. 2:1977;180-183
42. CDC Cardiac adverse events following smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;248-250
43. Finlay-Jones L.R. Fatal myocarditis after vaccination against smallpox: report of a case. N Engl J Med. 270:1964;41-42
44. Saurina G., Shirazi S., Lane J.M., Daniel B., DiEugenia L. Myocarditis after smallpox vaccination: a case report. Clin Infect Dis. 37:2003;145-146
45. CDC Update. Cardiac and other adverse events following civilian smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;639-642
46. American Academy of Dermatology AAD supplemental statement regarding contraindications to smallpox vaccination. 2003;. Available at http://www.aad.org/BioInfo/ Presidents%20Message_statement2_10_03.pdf. Accessed 30 June 2003
47. Naleway A.L., Belongia E.A., Greenlee R.T., Kieke B.A., Chen R.T., Shay D.K. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination. Ann Intern Med. 139:2003;1-7
48. Centers for Disease Control and Prevention Smallpox vaccination information for women who are pregnant or breastfeeding, 2003. Available at http://www.bt.cdc.gov/agent/smallpox/vaccination/preg-factsheet.asp. Accessed 30 June 2003
49. Engler R.J., Kenner J., Leung D.Y. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol. 110:2002;357-365
50. Centers for Disease Control and Prevention Fact sheet: smallpox vaccine and heart problems, 2003. Available at http://www.bt.cdc.gov/agent/smallpox/ vaccination/heartproblems.asp. Accessed 30 June 2003
51. CDC Update. Adverse events following smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;278-282
52. CDC Notice to Readers. Supplemental recommendations on adverse events following smallpox vaccine in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 52:2003;282-284
53. Kemper A.R., Davis M.M., Freed G.L. Expected adverse events in a mass smallpox vaccination campaign. Effective Clin Pract. 5:2002;84-89. Available at http://www.acponline.org/journals/acp/marapr02/kemper.htm. Accessed 30 June 2003
54. Press A. First vaccinations show 1 in 3 soldiers exempt. Newsday. December 21:2002;A10
55. CDC Update. Adverse events following civilian smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;819-820
56. CDC Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;386-388
57. LeDuc J.W., Becher J. Current status of smallpox vaccine. Emerg Infect Dis. 5:1999;593-594
58. Weltzin R., Liu J., Pugachev K.V., Myers G.A., Coughlin B., Blum P.S., et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 9:2003;1125-1130
59. Stittelaar K.J., Osterhaus A.D. MVA: a cuckoo in the vaccine nest? Vaccine. 19:2001;v-vi
60. In search of a kinder, gentler vaccine. Science. 296:2002;1594
61. Belyakov I.M., Earl P., Dzutsev A., Kuznetsov V.A., Lemon M., Wyatt L., et al. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci USA. 100:2003;9458-9463
62. Hashizume S. The bases of a new low-virulent vaccinia virus strain, LC16m8. Rinsho To Uirusu. 3:1975;229-235
63. Morita M., Aoyama Y., Arita M., Amona H., Yoshizawa H., Hashizume S., et al. Comparative studies of several vaccinia virus strains by intrathalamic inoculation into cynomolgus monkeys. Arch Virol. 53:1977;197-208
64. Yamaguchi M., Kimura M., Hirayama M. Vaccination research group research report: Ministry of Health and Welfare special research: post-vaccination side effects and research regarding treatment of complications. Rinsho To Uirusu. 3:1975;269-279